Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 25-Sep-23 4:34 PM View:  | Clearside Biomedical, Inc. (CLSD) | 25-Sep-23 | Private Purchase | 10,000 | $0.86 | $8,600.00 | < 1% 3.58M to 3.59M | |
| 19-May-23 4:18 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-May-23 | Option Exercise | 3,750 | -- | -- | < 1% 3.58M to 3.58M | |
| 21-Dec-22 4:26 PM View: | Clearside Biomedical, Inc. (CLSD) | 21-Dec-22 | Private Purchase | 14,000 | $1.02 | $14,266.00 | < 1% 3.56M to 3.58M | |
| 19-Dec-22 7:41 PM View: | Clearside Biomedical, Inc. (CLSD) | 15-Dec-22 | Acquisition (other) | 8,522 | -- | -- | < 1% 4.96M to 4.97M | |
| 19-Dec-22 7:41 PM View: | Clearside Biomedical, Inc. (CLSD) | 15-Dec-22 | Disposition (other) | 1,406,510 | -- | -- | (28%) 4.97M to 3.56M | |
| 17-May-22 9:06 PM View: | Vigil Neuroscience, Inc. (VIGL) | 17-May-22 | Purchase | 14,893 | $2.97 | $44,189.00 | < 1% 1.54M to 1.56M | |
| 17-May-22 9:06 PM View: | Vigil Neuroscience, Inc. (VIGL) | 16-May-22 | Purchase | 21,802 | $2.76 | $60,221.50 | 1% 1.52M to 1.54M | |
| 28-Mar-22 4:44 PM View: | Vigil Neuroscience, Inc. (VIGL) | 28-Mar-22 | Purchase | 3,000 | $7.20 | $21,604.20 | < 1% 1.52M to 1.52M | |
| 11-Jan-22 9:20 PM View: | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion | 1,254,340 | -- | -- | 100% 0 to 1.25M | |
| 11-Jan-22 9:20 PM View: | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase | 265,000 | $14.00 | $3,710,000.00 | 21% 1.25M to 1.52M | |
| 18-Aug-21 10:00 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 18-Aug-21 | Market Purchase | 10,000 | $3.00 | $30,000.00 | 44% 22.94K to 32.94K | 7% |
| 12-Feb-21 5:22 PM View: | Clearside Biomedical, Inc. (CLSD) | 10-Feb-21 | Market Sale (Planned) | 32,873 | $4.43 | $145,627.00 | (< 1%) 3.47M to 3.44M | 42% |
| 24-Nov-20 4:04 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 24-Nov-20 | Market Purchase | 2,000 | $3.50 | $7,000.00 | 10% 20.94K to 22.94K | 3% |
| 24-Nov-20 4:04 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 23-Nov-20 | Market Purchase | 3,000 | $3.67 | $11,010.00 | 17% 17.94K to 20.94K | (2%) |
| 18-Nov-20 7:19 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 16-Nov-20 | Acquisition (other) | 2,144 | -- | -- | < 1% 2.47M to 2.47M | |
| 18-Nov-20 7:19 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 16-Nov-20 | Acquisition (other) | 10,586 | -- | -- | < 1% 2.47M to 2.48M | |
| 18-Nov-20 7:19 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 16-Nov-20 | Disposition (other) | 52,397 | -- | -- | (2%) 2.48M to 2.43M | |
| 26-Nov-19 4:33 PM View: | Clearside Biomedical, Inc. (CLSD) | 22-Nov-19 | Grant | 1,518,030 | $1.05 | $1,600,000.00 | 44% 3.47M to 4.99M | 143% |
| 03-Jul-19 4:28 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 01-Jul-19 | Market Sale (Planned) | 2,908 | $14.00 | $40,712.00 | (< 1%) 2.45M to 2.45M | 74% |
| 20-Jun-19 7:09 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 18-Jun-19 | Market Sale (Planned) | 400 | $14.00 | $5,600.00 | (< 1%) 2.45M to 2.45M | 74% |
| 06-Dec-18 5:41 PM View: | Clearside Biomedical, Inc. (CLSD) | 06-Dec-18 | Market Purchase | 8,000 | $1.36 | $10,880.00 | < 1% 3.47M to 3.47M | 98% |
| 06-Dec-18 9:15 AM View: | Phasebio Pharmaceuticals Inc (PHAS) | 04-Dec-18 | Purchase | 4,000 | $3.13 | $12,520.00 | < 1% 2.47M to 2.47M | |
| 24-Oct-18 4:19 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 22-Oct-18 | Conversion Duplicate | 2,158,050 | -- | -- | 18290% 11.8K to 2.17M | |
| 24-Oct-18 4:19 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 22-Oct-18 | Purchase Duplicate | 300,000 | $5.00 | $1,500,000.00 | 14% 2.17M to 2.47M | |
| 01-Jun-18 6:22 PM View: | G1 Therapeutics, Inc. (GTHX) | 30-May-18 | Market Sale | 800,000 | $48.00 | $38,400,000.00 | (11%) 7.32M to 6.52M | 58% |
| 23-May-18 8:46 PM View: | G1 Therapeutics, Inc. (GTHX) | 23-May-18 | Market Sale | 500 | $50.50 | $25,250.00 | (< 1%) 32.33M to 32.33M | 60% |
| 23-May-18 8:46 PM View: | G1 Therapeutics, Inc. (GTHX) | 22-May-18 | Market Sale | 5,900 | $50.85 | $300,016.00 | (< 1%) 32.34M to 32.33M | 61% |
| 23-May-18 8:46 PM View: | G1 Therapeutics, Inc. (GTHX) | 21-May-18 | Market Sale | 31,100 | $51.17 | $1,591,410.00 | (< 1%) 32.37M to 32.34M | 61% |
| 21-May-18 4:05 PM View: | Clearside Biomedical, Inc. (CLSD) | 18-May-18 | Market Sale | 61,139 | $13.16 | $804,589.00 | (2%) 3.53M to 3.47M | 80% |
| 21-May-18 4:05 PM View: | Clearside Biomedical, Inc. (CLSD) | 17-May-18 | Market Sale | 100,000 | $13.03 | $1,303,000.00 | (3%) 3.63M to 3.53M | 79% |
| 23-Mar-18 5:51 PM View: | Clearside Biomedical, Inc. (CLSD) | 23-Mar-18 | Market Sale | 5,231 | $12.02 | $62,876.60 | (< 1%) 3.63M to 3.63M | 78% |
| 23-Mar-18 5:51 PM View: | Clearside Biomedical, Inc. (CLSD) | 22-Mar-18 | Market Sale | 33,630 | $12.07 | $405,914.00 | (< 1%) 3.67M to 3.63M | 78% |
| 23-Mar-18 5:51 PM View: | Clearside Biomedical, Inc. (CLSD) | 21-Mar-18 | Market Sale | 100,000 | $12.27 | $1,227,000.00 | (3%) 3.77M to 3.67M | 78% |
| 07-Dec-17 5:10 PM View: | Clearside Biomedical, Inc. (CLSD) | 07-Dec-17 | Market Sale (Planned) | 5,000 | $6.13 | $30,650.00 | (< 1%) 3.77M to 3.77M | 56% |
| 07-Dec-17 5:10 PM View: | Clearside Biomedical, Inc. (CLSD) | 06-Dec-17 | Market Sale (Planned) | 15,000 | $6.09 | $91,350.00 | (< 1%) 3.79M to 3.77M | 56% |
| 07-Dec-17 5:10 PM View: | Clearside Biomedical, Inc. (CLSD) | 05-Dec-17 | Market Sale (Planned) | 15,000 | $6.37 | $95,550.00 | (< 1%) 3.8M to 3.79M | 58% |
| 04-Dec-17 5:01 PM View: | G1 Therapeutics, Inc. (GTHX) | 30-Nov-17 | Acquisition (other) | 995 | -- | -- | < 1% 8.25M to 8.25M | |
| 04-Dec-17 5:01 PM View: | G1 Therapeutics, Inc. (GTHX) | 30-Nov-17 | Disposition (other) | 99,513 | -- | -- | (1%) 8.25M to 8.15M | |
| 16-Nov-17 5:41 PM View: | Clearside Biomedical, Inc. (CLSD) | 16-Nov-17 | Market Sale (Planned) | 5,000 | $6.99 | $34,950.00 | (< 1%) 3.81M to 3.8M | 61% |
| 16-Nov-17 5:41 PM View: | Clearside Biomedical, Inc. (CLSD) | 15-Nov-17 | Market Sale (Planned) | 15,000 | $6.99 | $104,850.00 | (< 1%) 3.82M to 3.81M | 61% |
| 16-Nov-17 5:41 PM View: | Clearside Biomedical, Inc. (CLSD) | 14-Nov-17 | Market Sale (Planned) | 15,000 | $7.02 | $105,300.00 | (< 1%) 3.84M to 3.82M | 62% |
| 05-Oct-17 7:35 PM View: | Clearside Biomedical, Inc. (CLSD) | 05-Oct-17 | Market Sale (Planned) | 6,000 | $8.34 | $50,040.00 | (< 1%) 3.84M to 3.84M | 68% |
| 05-Oct-17 7:35 PM View: | Clearside Biomedical, Inc. (CLSD) | 04-Oct-17 | Market Sale (Planned) | 14,000 | $8.59 | $120,260.00 | (< 1%) 3.86M to 3.84M | 69% |
| 05-Oct-17 7:35 PM View: | Clearside Biomedical, Inc. (CLSD) | 03-Oct-17 | Market Sale (Planned) | 15,000 | $8.64 | $129,600.00 | (< 1%) 3.87M to 3.86M | 69% |
| 15-Sep-17 5:08 PM View: | Clearside Biomedical, Inc. (CLSD) | 15-Sep-17 | Market Sale (Planned) | 10,000 | $7.54 | $75,400.00 | (< 1%) 3.88M to 3.87M | 64% |
| 15-Sep-17 5:08 PM View: | Clearside Biomedical, Inc. (CLSD) | 14-Sep-17 | Market Sale (Planned) | 6,000 | $7.52 | $45,120.00 | (< 1%) 3.89M to 3.88M | 64% |
| 15-Sep-17 5:08 PM View: | Clearside Biomedical, Inc. (CLSD) | 13-Sep-17 | Market Sale (Planned) | 8,500 | $7.49 | $63,665.00 | (< 1%) 3.9M to 3.89M | 64% |
| 09-Aug-17 5:48 PM View: | Clearside Biomedical, Inc. (CLSD) | 09-Aug-17 | Market Sale (Planned) | 15,000 | $7.30 | $109,500.00 | (< 1%) 3.91M to 3.9M | 63% |
| 09-Aug-17 5:48 PM View: | Clearside Biomedical, Inc. (CLSD) | 08-Aug-17 | Market Sale (Planned) | 5,000 | $7.98 | $39,900.00 | (< 1%) 3.92M to 3.91M | 66% |
| 09-Aug-17 5:48 PM View: | Clearside Biomedical, Inc. (CLSD) | 07-Aug-17 | Market Sale (Planned) | 4,500 | $8.02 | $36,090.00 | (< 1%) 3.92M to 3.92M | 66% |